BCR and lymphoma: One mechanistic explanation of how upstream IGHV1-69 hotspot mutations can imprint persisting lymphoma-like signaling comes from the superior responses to IgM ligation for one of the lymphoma-derived BCRs with mutated CDR1 (BCR1).